Determination of Venous Thromboembolism Risk and Nursing Practices in Patients Hospitalized in Medical Services
1 other identifier
observational
157
1 country
2
Brief Summary
Together with individual predisposition to form vascular clots and clinical conditions that further increase this risk, venous thromboembolism (VTE) poses a significant additional morbidity and mortality risk for the majority of the world's population. Although VTE causes serious disability and death when undiagnosed, it is a medical condition that can be prevented when diagnosed early. Although all hospitalized patients are at risk of DVT, studies have shown that 75% of hospitalized patients are hospitalized in internal clinics.As a result of this observational study, it was aimed to determine the VTE risk levels of the patients from the time of hospitalization and to determine preventive nursing care for VTE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2024
CompletedFirst Submitted
Initial submission to the registry
May 31, 2024
CompletedFirst Posted
Study publicly available on registry
June 6, 2024
CompletedJune 10, 2024
June 1, 2024
Same day
May 31, 2024
June 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determination of IMPROVE risk model risk levels according to deep vein thrombosis and pulmonary embolism risk factors
IMPROVE VTE Risk modeli,the seven risk factors evaluated in this model are history of VTE, thrombophilia, cancer in remission within the last 5 years, lower extremity paralysis or paresthesia (leg falling to the bed within 5 seconds), immobilization (complete immobility in bed or chair for ≥ 1 day), ICU (ICU)/Coronary ICU hospitalization, Age ≥ 60 years. In this model with a maximum of 12 points; 0-1 point range is defined as low VTE risk, 2-3 point range as moderate VTE risk and 4 points and above high VTE risk,
21 February 2024
Secondary Outcomes (1)
Rate of implementation of nursing practices for VTE risk
21 February 2024
Interventions
Determination of VTE risk levels of patients using IMPROVE risk assessment tool according to deep vein thrombosis and pulmonary embolism risk factors
Eligibility Criteria
The population of the study will consist of patients hospitalized in the medical clinics of an Adult Hospital of a University. The Adult Hospital serving adult patients has a capacity of 801 beds and the number of beds allocated for medical services is 211.
You may qualify if:
- To be conscious,
- Consent of the patient's relatives to participate in the study in unconscious patients
- hours have passed since hospitalization
- The patient admitted to hospitalization has been pre-assessed by the nurse and the pre-assessment form and nurse observation form have been completed
You may not qualify if:
- Surgical patients
- Pregnant patients
- Refusing to participate in the study during the completion of the data collection forms.
- In unconscious patients, the patient's relatives did not give consent to participate in the study
- Unconscious patient whose relatives cannot be reached
- The patient admitted to hospitalization was not pre-assessed by the nurse and the pre-assessment form and nurse observation form were not filled out
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hacettepe University
Altındağ, Ankara, Turkey (Türkiye)
Hacettepe Uviversity
Ankara, Turkey (Türkiye)
Related Publications (1)
Skeik N, Westergard E. Recommendations for VTE Prophylaxis in Medically Ill Patients. Ann Vasc Dis. 2020 Mar 25;13(1):38-44. doi: 10.3400/avd.ra.19-00115.
PMID: 32273920RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Humeyra Zengin
Director of Nursing Services
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Nursing Services
Study Record Dates
First Submitted
May 31, 2024
First Posted
June 6, 2024
Study Start
February 21, 2024
Primary Completion
February 21, 2024
Study Completion
February 21, 2024
Last Updated
June 10, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share